Ticagrelor and absorb bioresorbable vascular scaffold implantation for recovery of vascular function after successful chronic total occlusion recanalization.
Phase of Trial: Phase IV
Latest Information Update: 24 Sep 2019
Price : $35 *
At a glance
- Drugs Ticagrelor (Primary) ; Clopidogrel
- Indications Arterial occlusive disorders; Coronary disorders
- Focus Therapeutic Use
- Acronyms TIGER-BVS
- 24 Sep 2019 Status changed from active, no longer recruiting to completed.
- 01 Jan 2018 Trial design of the study published in the Catheterization and Cardiovascular Interventions.
- 22 Dec 2017 Status changed from recruiting to active, no longer recruiting.